Driven By The Urgency Of Cancer Patients Who Need Effective Therapies
Our mission is to inspire hope by delivering targeted therapies for those battling cancers.
A Focused Pipeline Portfolio
By leveraging our deep expertise in structure-based drug discovery, translational research and patient-driven precision medicine, we have developed a pipeline of small molecule kinase inhibitor candidates for difficult-to-treat, genomically-defined cancers.
